We next evaluated the impacts of these IL-17A SNPs on clinicopathological characteristics of LUAD patients, including the cancer stage, primary tumor size, lymph node involvement, distant metastasis, and cell differentiation, and the results are shown in Table 3. The gene discussed is IL17A; the disease is neoplasm.